RxDoctor Payments Data

Kelly Isbell, DO

Family Medicine · Hurst, TXNPI 1326485335

Payments from drug & device makers

$214in general payments, 2019–2025

Across 12 payments — averaging $17.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bayer$39
  • Dynavax Technologies Corporation$39
  • Dexcom, Inc.$23
  • Pfizer$22
  • Xeris Pharmaceuticals, Inc.$17
  • GSK$17
  • plus $57 from 4 others

What the payments were for

  • Food & beverage$214100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Bayer2$39
Dynavax Technologies Corporation2$39
Dexcom, Inc.1$23
Pfizer1$22
Xeris Pharmaceuticals, Inc.1$17
GSK1$17
Novo Nordisk1$15
Amgen1$14
Lilly USA, LLC1$14
Avvisto Therapeutics, LLC1$14

How this compares

$214 in reported general payments places this provider in the 35th percentile of 8,760 family medicine providers in Texas.

See all family medicine providers in Texas

Medicare billing

Part B allowed, 2024
$41,660
Medicare patients
129
Services billed
607

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide37$66,116
TrulicityDulaglutide12$14,365
JanuviaSitagliptin Phosphate13$9,190
Lantus SolostarInsulin Glargine,hum.Rec.Anlog18$3,292
Rosuvastatin Calcium141$2,184
Atorvastatin Calcium134$1,547
Gabapentin67$1,540
Omeprazole55$1,429
Levothyroxine Sodium157$1,405
SynthroidLevothyroxine Sodium15$714
Oxybutynin Chloride ErOxybutynin Chloride14$708
ValacyclovirValacyclovir Hcl12$699
Simvastatin52$603
Diclofenac Sodium17$593
Amlodipine Besylate63$554

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$15$66,11637 claims
Lilly USA, LLCTrulicity$14$14,36512 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 35th percentile of 8,760 family medicine providers in Texas.

Other family medicine in Hurst

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →